PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40126P00275Bordetella-free baboons for pertussis infection — The Univeristy of Texas M.D. Anderson Cancer Center

The Univeristy of Texas M.D. Anderson Cancer Center holds $28.1M across 39 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. Competition previously drew 2 offers. Set-aside status: Unrestricted. Recompete timing centers on the Aug 31, 2027 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs
Awarding office
The Univeristy of Texas M.D. Anderson Cancer Center
Recipient
Aug 31, 2027
PoP end
$369K
Obligated
$369K
Potential
112990
NAICS
8820
PSC
Unrestricted
Set-aside
2 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number75F40126P00275
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentThe Univeristy of Texas M.D. Anderson Cancer Center
CAGE0KD38
UEIS3GMKS8ELA16
NAICS112990

No full NAICS 112990 intel page yet. Browse NAICS intelligence

PSC8820
Place of performanceHOUSTON TX
Pricing typeFirm Fixed Price
Extent competedCompeted Under SAP
PoP startAug 31, 2026
PoP end (current)Aug 31, 2027
Obligated$369K
Current value$369K
Potential value$369K

Bordetella-Free Baboons for Pertussis Infection and Vaccination Studies is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by The Univeristy of Texas M.D. Anderson Cancer Center. Estimated value $369K ($369K obligated). Current period of performance ends Aug 31, 2027. Last award drew 2 bidders. Place of performance: HOUSTON TX.

Bordetella-free baboons for pertussis infection and vaccination studies

Recompete timing

Public
● Expiring in 318 days

Current PoP ends Aug 31, 2027 (318 days remaining). Agencies typically plan 12–18 months ahead — at 10.4 months out, that window is already open. The buying decision is likely already in motion.

Want the durability read on 75F40126P00275? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

The Univeristy of Texas M.D. Anderson Cancer Center — $28.1M obligated across 39 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($28.1M) · all agencies
Department of Health and Human Services (HHS)$27.0M · 96%Department of Veterans Affairs (VA)$1.1M · 4%
Open full company profile →

Related awards

Same incumbent
75N91019F00131
REPURPOSING OF MACROLIDE ANTIBIOTIC CLARITHROMYCIN FOR THE PREVENTION OF LUNG AND BREAST C…
$8.7M
Apr 14, 2027
75F40126P00158
BORDETELLA-FREE BABOON STUDY
$206K
Aug 9, 2027
36C24524P0903
MED PHYSICS PEER REVIEW SERVICES
$1.1M
Sep 30, 2027
HHSH250201000011C
HSB88 C 327 NATIONAL CORD BLOOD INVENTORY
$30.4M
Sep 24, 2028
75F40125C00075
BAA-MD ANDERSON-STATISTICAL DESIGNS AND CONSIDERATIONS FOR DOSE OPTIMIZATION FY25C1FP6
$1.2M
Sep 29, 2028

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75F40126P00275?

75F40126P00275 (Bordetella-free baboons for pertussis infection) is a Fda Office Of Acq Grant Svcs award with a potential value of $369K, currently held by The Univeristy of Texas M.D. Anderson Cancer Center. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40126P00275?

Fda Office Of Acq Grant Svcs awarded 75F40126P00275 to The Univeristy of Texas M.D. Anderson Cancer Center (potential $369K).

Who is the incumbent on 75F40126P00275?

The Univeristy of Texas M.D. Anderson Cancer Center is the incumbent with $28.1M across 39 related awards in SCOUT’s public footprint. The current period of performance ends Aug 31, 2027.

When does The Univeristy of Texas M.D. Anderson Cancer Center’s 75F40126P00275 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75F40126P00275? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40126P00275